Reuters Pharma USA 2026

PhiladelphiaMonday 16th - Tuesday 17th March 2026

Join Inizio in Philadelphia for Reuters Pharma USA.

Join Inizio at Reuters Pharma USA 2026 from March 16 – 17, as we bring Intelligent Commercialization™ to life – connecting data, technology, AI, and human expertise to help life sciences teams launch smarter, stay focused, and deliver measurable impact.

As well as our presence at booth #521, we’re proud to showcase our teams from Inizio Ignite and Inizio Engage who will be delivering live sessions during the event.

Featured session.

​Inizio Engage: Designing insight-driven patient support: What should we be measuring across the journey

Day 1 | Time: 14:45-15:45 ET

Presenters: Chris Savage, Managing Director, Propensity4, an Inizio Engage Company, Sandhya Puliyampotta, Analytics Manager, Propensity4, an Inizio Engage Company, Adam Booth, Analytics Director, Propensity4, an Inizio Engage Company

  • Identify the critical stages of the patient journey from enrollment to adherence and define which journey-wide and stage-specific insights are most important to track to improve experience, accelerate time to therapy, and reduce friction.
  • Explore where delays, breakdowns, and drop-off risk occur across access, affordability, and leading indicators that could enable earlier, more effective intervention.
  • Which KPIs, behavioral signals, and outcome measures should be monitored to quantify intervention effectiveness, guide continuous improvement, and deliver measurable impact for patients and providers

Learn more​​

Featured session.

​​​Inizio Ignite: Accelerating launch success through strategic focus and disciplined execution

Day 1 | 4:20–4:40pm ET

Presenters: Matt Riordan, Group President, Putnam; Inizio Ignite

  • Ruthlessly prioritize to achieve deliberate focus on target customers, segments, and messages, resisting over-fragmentation
  • Translate launch strategy into an actionable launch roadmap that drives cross-functional alignment and addresses both success enablers and potential barriers
  • Enable fast, targeted course correction by maintaining visibility into early execution signals across field behavior, HCP understanding, access, and patient experience

Learn more

Get in touch to speak to our team:

* indicates a required field